Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The Gifts for the Gods exhibition in Manchester breaks new ground for historians in their fascination with ancient Egypt.
Coronation Street actor Ryan Thomas is to quit the show after more than 15 years.
A Liverpool fan who died in the Hillsborough disaster asked when the crush was going to stop, his inquest has hear